Recognising the critical need to provide ongoing aid as well as emergency humanitarian relief, Pfizer has a three part approach, including medicine donations, cash grants, and other access programmes.

Medicine Donations

Pfizer believes that medicine donations play an important role in supporting communities around the world. Most of Pfizer’s product donations, which are managed through established NGO partners, are designed to address an expressed need, providing underserved communities with access to potentially life-saving medicines and vaccines.

For example, to support the global strategy towards attempting to eliminate blinding trachoma by the year 2030,¹ Pfizer has worked with the International Trachoma Initiative (ITI) and the World Health Organization (WHO) since 1998 by providing antibiotic donations.²

Here in the UK, we've been supporting the International Health Partners, Europe’s largest coordinator of donated healthcare products, for more than 15 years. Find out more.

Cash Grants

In an effort to reach as many people as possible, we support a number of organisations responding to global disasters such as earthquakes, disease outbreaks and humanitarian crises.

In recent years, The Pfizer Foundation* and Pfizer have provided cash grants to various NGOs providing aid during emergencies such as the refugee crisis in Europe and the Middle East, the Zika outbreak, and Hurricane Matthew in Haiti and the United States.

Humanitarian Assistance Programmes

Every day, Pfizer colleagues around the world work collaboratively with governments, non-governmental organisations (NGOs), Civil Service Organisations (CSOs), healthcare providers, and payers to help provide countries with access to our medicines, vaccines and products through our humanitarian assistance programmes.

For example, through a collaboration with Gavi, the Vaccine Alliance, we are helping to broaden access to vaccines across the world's poorest countries. Additionally, Pfizer believes that to tackle some of the health challenges faced in low-income countries, we must look beyond access to medicines and help address the need for greater education amongst the health care workers at the forefront of delivering care.